MedPath

Effect of Intermittent ThetaBurst Stimulation in Treatment-resistant Bipolar Depression

Not Applicable
Terminated
Conditions
Bipolar Depression
Registration Number
NCT02740244
Lead Sponsor
Hôpital le Vinatier
Brief Summary

The aim is to evaluate the evaluate the clinical interest and the safety of repetitive transcranial magnetic stimulation (rTMS) delivered as intermittent Theta burst stimulation(iTBS) on severity of depression in patients with treatment-resistant bipolar disorder.

Detailed Description

Methods: A double-blind randomized sham-controlled pilot study will be conducted in 40 patients with bipolar treatment-resistant depression receiving either active (n=20) or sham (n=20) iTBS over the left dorsolateral prefrontal cortex.

Depression severity will be assessed by an investigator blinded to iTBS condition before and after 10 to 30 iTBS sessions depending on remission onset. Remission will be defined as Beck Depression Inventory, BDI score\<10.

Objective/Hypothesis: The investigators hypothesized the superiority of active iTBS over sham ITBS

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Bipolar disorder according to Diagnostic and Statistical Manual of Mental Disorders, DSM-IV criteria
  • Montgomery and Asberg depression scale > 20
Exclusion Criteria
  • other psychiatric features, rapid cycles
  • Benzodiazepines intake
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory2 time point measure, before and after the end of stimulation sessions (changes from baseline BDI scores at 6 weeks)

Self-reported clinical scale with 13 items

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.